Evidence map›Paper›PMID 29864141›Full record

ArticlePLoS pathogens2018

Defects in intracellular trafficking of fungal cell wall synthases lead to aberrant host immune recognition.

Shannon K Esher, Kyla S Ost, Maria A Kohlbrenner, Kaila M Pianalto, Calla L Telzrow, Althea Campuzano, Connie B Nichols, Carol Munro, Floyd L Wormley, J Andrew Alspaugh

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Acetylation and accessibility ofCell surface (Amsterdam, Netherlands) · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Lack of an atypical PDR transporter generates an immunogenicbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Shannon K EsherDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.ORCID 0000-0001-5212-0432
Kyla S OstDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.
Maria A KohlbrennerDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.ORCID 0000-0001-8519-9562
Kaila M PianaltoDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.ORCID 0000-0002-1427-0154
Calla L TelzrowDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.ORCID 0000-0003-2686-5726
Althea CampuzanoDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas, United States of America.ORCID 0000-0003-3159-7113
Connie B NicholsDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.
Carol MunroMRC Centre for Medical Mycology, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom.ORCID 0000-0003-0761-1755
Floyd L WormleyDepartment of Biology, University of Texas at San Antonio, San Antonio, Texas, United States of America.ORCID 0000-0001-9290-3925
J Andrew AlspaughDepartments of Molecular Genetics and Microbiology/Medicine, Duke University School of Medicine, Durham, NC, United States of America.
Duke University · USThe University of Texas at San Antonio · USUniversity of Aberdeen · GB

Funding

UTSA RISE Research Training ProgramR25GM060655 · NIGMS · UNIVERSITY OF TEXAS SAN ANTONIO · PI BAREA-RODRIGUEZ, EDWIN J · 2000 to 2022
$21.6M
ORGANIZATION AND FUNCTIONS OF CELLULAR STRUCTUREST32GM007184 · NIGMS · DUKE UNIVERSITY · PI JINKS-ROBERTSON, SUE · 1985 to 2019
$18.2M
Trehalose Pathway for Antifungal Targets and InhibitorsP01AI104533 · NIAID · DUKE UNIVERSITY · PI PERFECT, JOHN R. · 2015 to 2019
$9.0M
Coordinated Regulation of Virulence Genes in C. neoformansR01AI074677 · NIAID · DUKE UNIVERSITY · PI ALSPAUGH, ANDREW, WORMLEY, FLOYD L. · 2011 to 2020
$4.0M
Coordinated Regulation of Virulence Genes in C. neoformansR56AI074677 · NIAID · DUKE UNIVERSITY · PI ALSPAUGH, ANDREW · 2009 to 2010
$608k
Medical Research Council MR/N006364/1NIAID NIH HHS P01 AI104533NIAID NIH HHS R01 AI074677NIAID NIH HHS R56 AI074677NIGMS NIH HHS R25 GM060655NIGMS NIH HHS T32 GM007184Wellcome TrustWellcome Trust 097377Wellcome Trust 101873
6 · The paper itself

Abstract

The human fungal pathogen, Cryptococcus neoformans, dramatically alters its cell wall, both in size and composition, upon entering the host. This cell wall remodeling is essential for host immune avoidance by this pathogen. In a genetic screen for mutants with changes in their cell wall, we identified a novel protein, Mar1, that controls cell wall organization and immune evasion. Through phenotypic studies of a loss-of-function strain, we have demonstrated that the mar1Δ mutant has an aberrant cell surface and a defect in polysaccharide capsule attachment, resulting in attenuated virulence. Furthermore, the mar1Δ mutant displays increased staining for exposed cell wall chitin and chitosan when the cells are grown in host-like tissue culture conditions. However, HPLC analysis of whole cell walls and RT-PCR analysis of cell wall synthase genes demonstrated that this increased chitin exposure is likely due to decreased levels of glucans and mannans in the outer cell wall layers. We observed that the Mar1 protein differentially localizes to cellular membranes in a condition dependent manner, and we have further shown that the mar1Δ mutant displays defects in intracellular trafficking, resulting in a mislocalization of the β-glucan synthase catalytic subunit, Fks1. These cell surface changes influence the host-pathogen interaction, resulting in increased macrophage activation to microbial challenge in vitro. We established that several host innate immune signaling proteins are required for the observed macrophage activation, including the Card9 and MyD88 adaptor proteins, as well as the Dectin-1 and TLR2 pattern recognition receptors. These studies explore novel mechanisms by which a microbial pathogen regulates its cell surface in response to the host, as well as how dysregulation of this adaptive response leads to defective immune avoidance.

Indexed as

Animalsbeta-GlucansCells, CulturedCell WallCryptococcosisCryptococcus neoformansDendritic CellsFemaleFungal ProteinsHost-Pathogen InteractionsHumansImmune EvasionMacrophagesMaleMiceMice, Inbred BALB Cbeta-GlucansFungal ProteinsReceptors, Pattern Recognition

Identifiers

PMID29864141
PMCPMC6002136
OpenAlexW2806093302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.